Forte Biosciences FBRX
FBRX
$76.99 +0.00 (+0.00%)
At close: Aug 28, 2026 · 4:00 PM EDT

Forte Biosciences (FBRX) Other Non-Current Liabilities (2018 - 2026)

Updated

Forte Biosciences' Other Non-Current Liabilities came in at $1.66 million for Q2 2026, up 12.5% from the prior quarter.

Analysis

Forte Biosciences (FBRX) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends

At the end of FY2025, Forte Biosciences' Other Non-Current Liabilities was $1.04 million.

  • The Q2 2026 figure represents the highest quarterly Other Non-Current Liabilities since Q1 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Forte Biosciences 1.58 Bn 1.38 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.66 Mn
Mar 31, 2026 1.48 Mn
Dec 31, 2025 1.04 Mn
Dec 31, 2019 81,000.00
Sep 30, 2019 81,000.00
Mar 31, 2019 2.30 Mn
Dec 31, 2018 2.20 Mn
Sep 30, 2018 2.03 Mn
Jun 30, 2018 1.55 Mn
Mar 31, 2018 160,000.00
API Access

Forte Biosciences Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=FBRX&period=max&api_key=YOUR_API_KEY